TARSF (TARSF)
Track the next or latest earnings date for TARSF, review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
www.stocktitan.net · 2 weeks ago
Tarsus Pharmaceuticals’ Q1 2026 revenue surged to $162.1M, driven by XDEMVY sales and China license revenue, while net loss narrowed to $7.0M as commercialization and R&D spending expanded.
TARSF: Alianza Minerals Ltd Latest Stock Price, Analysis, News and Trading Ideasstocktwits.com · Recent
Get real-time Alianza Minerals Ltd (TARSF) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.
TARSF Stock Price Quote | Morningstarwww.morningstar.com · Recent
See the latest Silver North Resources Ltd stock price (TARSF:PINX), related news, valuation, dividends and more to help you make your investing decisions.
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Share Price Weakness And Pipeline Growth Expectations - Simply Wall St Newssimplywall.st · 2 weeks ago
Event context and recent stock performance Tarsus Pharmaceuticals (TARS) has attracted investor attention recently as its share price has moved over the past month and past 3 months, with the stock last closing at US$63.96 and a market value of about US$2.8b.
Tarsus investor conference schedule runs May 12-26 | TARS Stock Newswww.stocktitan.net · 2 weeks ago
Webcasts cover Bank of America, H.C. Wainwright and Stifel events. Why it matters: investors can hear management on May 12, May 19 and May 26.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: N/A
Revenue estimate: N/A
Market cap: N/A
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Feb 20, 2026 | 2025-12-31 | Time not specified | N/A | N/A |